| 000 | 00876 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512023750.0 | ||
| 264 | 0 | _c19880302 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(88)91104-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCotes, J E | |
| 245 | 0 | 0 |
_aAirflow limitation--reversible or irreversible? _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 1988 |
||
| 300 |
_a247 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aForced Expiratory Flow Rates |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Diseases _xdrug therapy |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8579 _gp. 247 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(88)91104-x _zAvailable from publisher's website |
| 999 |
_c2898920 _d2898920 |
||